Series date: 
01/07/2021 - 4:00pm EST to 12/31/2024 - 5:00pm EST

Sessions

Session Date
Safety of Therapeutic Apheresis in Children and Adolescents 08/10/2022 - 3:30pm to 4:30pm EDT
A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus Host Disease 08/31/2022 - 3:30pm to 4:30pm EDT
Safety and Tolerability of Solvent/Detergent-Treated Plasma for Pediatric Patients Requiring Therapeutic Plasma Exchange 10/19/2022 - 3:30pm to 4:30pm EDT
Comprehensive guide to managing a chronic automated red cell exchange program in sickle cell disease 11/09/2022 - 3:30pm to 4:30pm EST
Drug dosing in patients undergoing therapeutic plasma exchange 01/25/2023 - 3:30pm to 4:30pm EST
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant 02/22/2023 - 3:30pm to 4:30pm EST
The ADAPT trial for myasthenia gravis 05/31/2023 - 3:30pm to 4:03pm EDT
Efficacy and cost of double filtration plasmapheresis in severe hypertriglyceridemia-induced pancreatitis: A retrospective observational study 08/09/2023 - 3:30pm to 4:30pm EDT
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturer 08/16/2023 - 3:30pm to 4:30pm EDT
Ethylene oxide-type hypersensitivity reactions in G-CSF mobilized, peripheral blood hematopoietic progenitor cell donors 09/27/2023 - 3:30pm to 4:30pm EDT

Pages